ACTUATE THERAPEUTICS - PATENT EXPECTED TO STRENGTHEN IP PORTFOLIO AND SUPPORT FUTURE COMMERCIALIZATION OF ORAL ELRAGLUSIB

Reuters · 11/02 13:02

Please log in to view news